Employees: 02 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2020-05-19 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LANOBRE (15270), Cantal
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELASU PHARMACIE DE LANOBRE : revenue, balance sheet and financial ratios
SELASU PHARMACIE DE LANOBRE is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LANOBRE (15270),
this company of category PME
shows in 2022 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELASU PHARMACIE DE LANOBRE (SIREN 883978942)
Indicator
2024
2023
2022
2021
2020
Revenue
N/C
N/C
1 435 235 €
N/C
N/C
Net income
360 785 €
340 447 €
442 294 €
327 133 €
81 185 €
EBITDA
N/C
N/C
449 566 €
N/C
N/C
Net margin
N/C
N/C
30.8%
N/C
N/C
Revenue and income statement
In 2024, SELASU PHARMACIE DE LANOBRE generates positive net income of 361 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2024: 81 k€ -> 361 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
360 785 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 189%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
189.384%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
31.27%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELASU PHARMACIE DE LANOBRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
Debt ratio
469.566
144.231
123.264
212.148
189.384
Financial autonomy
15.162
36.998
39.898
28.397
31.27
Repayment capacity
None
None
1.307
None
None
Cash flow / Revenue
None%
None%
31.143%
None%
None%
Sector positioning
Debt ratio
189.382024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+14 pts over 3 years
In 2024, the debt ratio of SELASU PHARMACIE DE LANOBRE (189.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
31.27%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-12 pts over 3 years
In 2024, the financial autonomy of SELASU PHARMACIE DE LANOBRE (31.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
1.31 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of SELASU PHARMACIE DE LANOBRE (1.31) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 669.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
669.861
Liquidity indicators evolution SELASU PHARMACIE DE LANOBRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
Liquidity ratio
278.215
556.975
556.344
569.721
669.861
Interest coverage
None
None
0.447
None
None
Sector positioning
Liquidity ratio
669.862024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of SELASU PHARMACIE DE LANOBRE (669.86) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.45x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of SELASU PHARMACIE DE LANOBRE (0.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELASU PHARMACIE DE LANOBRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
163 100 €
0 €
0 €
Inventory turnover (days)
0
0
35
0
0
Customer payment term (days)
0
0
6
0
0
Supplier payment term (days)
0
0
40
0
0
Positioning of SELASU PHARMACIE DE LANOBRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELASU PHARMACIE DE LANOBRE is estimated at
5 036 825 €
(range 3 507 565€ - 7 535 378€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3507k€5036k€7535k€
5 036 825 €Range: 3 507 565€ - 7 535 378€
NAF 5 année 2024
Valuation method used
Net Income Multiple
360 785 €
×
14.0x
=5 036 825 €
Range: 3 507 566€ - 7 535 379€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELASU PHARMACIE DE LANOBRE with other companies in the same sector:
Frequently asked questions about SELASU PHARMACIE DE LANOBRE
What is the revenue of SELASU PHARMACIE DE LANOBRE ?
The revenue of SELASU PHARMACIE DE LANOBRE in 2022 is 1.4 M€.
Is SELASU PHARMACIE DE LANOBRE profitable?
Yes, SELASU PHARMACIE DE LANOBRE generated a net profit of 361 k€ in 2024.
Where is the headquarters of SELASU PHARMACIE DE LANOBRE ?
The headquarters of SELASU PHARMACIE DE LANOBRE is located in LANOBRE (15270), in the department Cantal.
Where to find the tax return of SELASU PHARMACIE DE LANOBRE ?
The tax return of SELASU PHARMACIE DE LANOBRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELASU PHARMACIE DE LANOBRE operate?
SELASU PHARMACIE DE LANOBRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart